A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib

Yinli Shi; Shuang Guan; Sicun Wang; Muzhi Li; Yanan Yu; Jun Liu; Weibin Yang; Zhong Wang

doi:10.1371/journal.pone.0338188

Loading metrics

Open Access

Peer-reviewed

Research Article

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib

Yinli Shi ,

Contributed equally to this work with: Yinli Shi, Shuang Guan, Sicun Wang

Roles Conceptualization, Methodology, Writing – original draft

¶☯ These authors have contributed equally to this work and share first authorship

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Shuang Guan ,

Contributed equally to this work with: Yinli Shi, Shuang Guan, Sicun Wang

Roles Conceptualization, Methodology, Writing – review & editing

¶☯ These authors have contributed equally to this work and share first authorship

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Sicun Wang ,

Contributed equally to this work with: Yinli Shi, Shuang Guan, Sicun Wang

Roles Conceptualization, Methodology, Writing – review & editing

¶☯ These authors have contributed equally to this work and share first authorship

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Muzhi Li,

Roles Writing – review & editing

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Yanan Yu,

Roles Writing – review & editing

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Jun Liu,

Roles Writing – review & editing

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
⨯
Weibin Yang ,

Roles Formal analysis, Writing – review & editing

* E-mail: ywb823@126.com (WY); zhonw@vip.sina.com (ZW)

Affiliation Graduate School of China Academy of Chinese Medical Sciences, Beijing, China
⨯
Zhong Wang

Roles Conceptualization, Methodology, Project administration, Writing – review & editing

* E-mail: ywb823@126.com (WY); zhonw@vip.sina.com (ZW)

Affiliation Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China

https://orcid.org/0000-0003-0975-9251

⨯

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib

Yinli Shi,
Shuang Guan,
Sicun Wang,
Muzhi Li,
Yanan Yu,
Jun Liu,
Weibin Yang,
Zhong Wang

Published: December 15, 2025
https://doi.org/10.1371/journal.pone.0338188

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Immune receptor signaling
Is the Subject Area "Immune receptor signaling" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Urinary tract infections
Is the Subject Area "Urinary tract infections" applicable to this article?

Thanks for your feedback.
Respiratory infections
Is the Subject Area "Respiratory infections" applicable to this article?

Thanks for your feedback.